1. 天津中医药大学第一附属医院
2. 天津中医药大学研究生部
纸质出版:2013
移动端阅览
[1]赵远红,李正,贾英杰,孙一予,于洁,柳欢庆,姜委明,韩素恒.加味清心扶脾方对铂类方案致化疗相关呕吐的作用[J].中医杂志,2013,54(06):492-495+521.
ZHAO Yuanhong 1, LI Zheng 1, JIA Yingjie 1, et al. Effect of Supplemented Qingxin Fupi Formula on Platinum-based Chemotherapy-Induced Nausea and Vomiting[J]. Journal of Traditional Chinese Medicine2013, 54(6): 492-495.
[1]赵远红,李正,贾英杰,孙一予,于洁,柳欢庆,姜委明,韩素恒.加味清心扶脾方对铂类方案致化疗相关呕吐的作用[J].中医杂志,2013,54(06):492-495+521. DOI: 10.13288/j.11-2166/r.2013.06.014.
ZHAO Yuanhong 1, LI Zheng 1, JIA Yingjie 1, et al. Effect of Supplemented Qingxin Fupi Formula on Platinum-based Chemotherapy-Induced Nausea and Vomiting[J]. Journal of Traditional Chinese Medicine2013, 54(6): 492-495. DOI: 10.13288/j.11-2166/r.2013.06.014.
目的评价加味清心扶脾方对铂类方案致化疗相关呕吐(CINV)的疗效及其安全性。方法将76例CINV患者随机分为观察组36例和对照组40例
两组均予含铂类方案常规给药
观察组化疗前1~2d联用加味清心扶脾方
每3h温服1次
每次约100ml
连用14d
休息7d
21d为1个周期。2个周期后观察患者化疗后第1、3、7天呕吐症状分级及止吐疗效
化疗后伴随症状评分及疗效
化疗完成率及KPS评分、PS体力状况评分、生活质量(QOL量表)、不良反应等。结果化疗后第1、3、7天观察组恶心呕吐0~Ⅳ级例数均较对照组明显减少
差异有统计学意义(P<0.05);观察组化疗后第1、3、7天恶心呕吐有效率均明显高于对照组
差异有统计学意义(P<0.05);完全控制率两组比较差异无统计学意义(P>0.05)。化疗后14d观察组腹胀、胃脘或胁肋胀满、嗳气反酸、口苦口干及胃中嘈杂、饮食减少、气短、神疲乏力改善均明显优于对照组(P<0.05或P<0.01)。观察组化疗完成率(88.2%)明显优于对照组(64.9%)(P<0.05);观察组KPS评分、PS体力状况评分、QOL量表评分明显优于对照组(P<0.05);两组不良反应比较差异无统计学意义(P>0.05)。结论加味清心扶脾方可有效抑制CINV
在一定程度上缓解消化道伴随症状
提高化疗完成率
改善生活质量和体力状况
稳定体重
且无明显不良反应。
Objective To evaluate the efficacy and safety of Supplemented Qingxin Fupi Formula (Supplemented Heart-Clearing Spleen-Supporting Formula
S QFF) for platinum-based chemotherapy-induced nausea and vomiting (C INV).Methods Totally 76CINV patients were randomized into the observation group (3 6cases) and control group (4 0cases).Both groups were given platinum-based chemotherapy.The patients in the observation group were orally taken 100ml SQFF once every 3 hours since one or two days before the chemotherapy
for 14days and following a latency of 7days.One treatment course las-ted for 21days.The vomiting degree
vomiting times
associated symptoms
body weight
Karnofsky score (K FS)
perform-ance status (P S)
the European Organization for Research and Treatment of Cancer (E ORTC) Quality of Life Questionnaires (Q LQ)
chemotherapy completion rate
liver function and kidney function were observed after two treatment courses.Results Compared with the control group
the vomiting degree decreased significantly in the observation group on the 1st
3rd and 7th day of chemotherapy (P<0.05).The effective rates of nausea and vomiting in the observation group were significantly higher than those in the control group on the 1st
3rd and 7th day of chemotherapy (P<0.05).There was no significant difference between groups in the full control rate (P>0.05).Comparing with the control group
the bloating
epigastric or hypochondri-ac fullness
belching
acid reflux
bitter taste
dry mouth
poor appetite
shortness of breath and fatigue were significantly re-lieved in the observation group on the 14th day of chemotherapy (P<0.05or P<0.01).The chemotherapy-done rate was 88.2%in the observation group
which was superior to 64.9%in the control group (P<0.05).The scores of KPS
PS and EORTC QLQ in the observation were superior to those in the control group (P<0.05).There was no significant difference be-tween groups in the toxic or side effect (P>0.05).Conclusion SQFF combined with platinum protocol is effective in inhibi-ting CINV
relieving digestive symptoms
increasing chemotherapy-done rate
improving quality of life and performance status and stabling bodyweight
with no obvious toxic or side effect.
0
浏览量
249
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号